Title |
Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm
|
---|---|
Published in |
Trends in Molecular Medicine, April 2007
|
DOI | 10.1016/j.molmed.2007.03.003 |
Pubmed ID | |
Authors |
Tarik F. Massoud, Sanjiv S. Gambhir |
Abstract |
Molecular imaging is a rapidly emerging field, providing noninvasive visual quantitative representations of fundamental biological processes in intact living subjects. Fundamental biomedical research stands to benefit considerably from advances in molecular imaging, with improved molecular target selection, probe development and imaging instrumentation. The noninvasiveness of molecular imaging technologies will also provide benefit through improved patient care. Molecular imaging endpoints can be quantified, and therefore are particularly useful for translational research. Integration of the two disciplines of molecular imaging and molecular medicine, combined with systems-biology approaches to understanding disease complexity, promises to provide predictive, preventative and personalized medicine that will transform healthcare. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Libya | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 2 | 2% |
Austria | 1 | 1% |
South Africa | 1 | 1% |
India | 1 | 1% |
United Kingdom | 1 | 1% |
Egypt | 1 | 1% |
Unknown | 81 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 21 | 24% |
Researcher | 15 | 17% |
Professor > Associate Professor | 11 | 13% |
Professor | 7 | 8% |
Student > Bachelor | 6 | 7% |
Other | 17 | 19% |
Unknown | 11 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 20% |
Agricultural and Biological Sciences | 14 | 16% |
Chemistry | 11 | 13% |
Engineering | 7 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Other | 19 | 22% |
Unknown | 14 | 16% |